Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by wildbird1on Jan 24, 2019 11:21am
149 Views
Post# 29275636

RE:H.R. 931 Unanimous approval by Congress

RE:H.R. 931 Unanimous approval by Congress
Very good post Nailbiter1....

If you read the 2018 Investor Presentation on Genenews Website.

Genenews said (Quote)...

High Risk Employees,
1.2 Million FireFighters
% over age 40 = 48%=576,000
Assumption-December 2019,
10% Penetration=57,000x $350=$20 Million

(End of Quote)

This quote seem to indicate that Genenews is already working to grab a small part(for now) of the H.R. 931 testing program.

Before long we could see a PressRelease on this subject.


Nailbiter1 wrote:

They're Never Late Reaching Us...
Why Be Late Reaching Them?

Introducing MyCancerRisk: A Program for First Responders MyCancerRisk is a program to help improve cancer survival among First Responders through early interventions.Our cancer risk assessment tests can be performed at the same time as a routine blood draw. Unlike other tests that identify cancer in its later stages, our tests can help identify early cancer indicators that give healthcare providers the information they need to monitor cancer risk and launch early interventions to improve patient outcomes.

(June 22, 2018) Earlier today, the House unanimously approved H.R. 931, the Firefighter Cancer Registry Act. The bipartisan legislation creates a specialized national registry to provide researchers and epidemiologists with the tools and resources needed to improve research collection activities related to the monitoring of cancer incidence among firefighters.

The House had previously passed the bill by voice vote on September 12, 2017. However, on May 10th, the Senate amended the bill before approving it by unanimous consent.

H.R. 931 was introduced by Congressman Chris Collins (NY-27) and Congressman Bill Pascrell, Jr. (NJ-9). Similar legislation, S. 382, was introduced in the Senate by Senator Robert Menendez (NJ) and Senator Lisa Murkowski (AK).

---------------------------------------------------------

More recently, the US Government just signed into federal law the Firefighter Cancer Registry Act of 2018 (H.R. 931). With this decisive action, the federal government has taken the first steps towards establishing a one-of-a-kind national cancer registry specifically for firefighters.

---------------------------------------------------------

Phoenix-area first responders will soon receive free cancer screening Max Gorden
Multimedia Journalist
Posted Oct 10, 2018
Cancer is the No. 1 killer of first responders, said Dr. Vershalee Shukla of Vincere Cancer Center.

PHOENIX (3TV / CBS 5) -- A new program will provide free cancer screening services for first responders across the Valley.

Police and firefighters will be eligible for the screening services at nine different cancer treatment centers. Theyll also receive follow-up consultation care.



Bullboard Posts